FDA.reportPublic FDA data

eluxadoline 75 MG Oral Tablet [Viberzi]

RxCUI
1653792
RxNorm name
eluxadoline 75 MG Oral Tablet [Viberzi]
Display name
eluxadoline 75 MG Oral Tablet [Viberzi]
Full name
eluxadoline 75 MG Oral Tablet [Viberzi]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ViberziELUXADOLINEAllergan, Inc.7821bd40-4c84-4984-951b-6436ae20421a2024-07-16Warnings, Adverse reactionsExact identifier
rxcui: 1653792

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7821bd40-4c84-4984-951b-6436ae20421aViberzi 75 MG Oral Tablet [PSN] · eluxadoline 75 MG Oral Tablet [Viberzi] [SBD] · Viberzi 75 MG Oral Tablet [SY]327These highlights do not include all the information needed to use VIBERZI safely and effectively. See full prescribing information for VIBERZI . VIBERZI (eluxadoline) tablets, for oral use , C IV Initial U.S. Approval: 201520240716